Regulus Therapeutics (RGLS): Q1 EPS of -$0.20 misses by $0.09. Revenue of $3.2M beats by $0.05M....

|About: Regulus Therapeutics (RGLS)|By:, SA News Editor
Regulus Therapeutics (RGLS): Q1 EPS of -$0.20 misses by $0.09. Revenue of $3.2M beats by $0.05M. (PR)